San Antonio, TX (September 20, 2002) – A new analysis of scientific data presented at today's meeting of the American Society for Bone and Mineral Research (ASBMR) showed that a 5 mg dose of Actonel® ...
Cincinnati, Ohio; Bridgewater, N.J. (February 10, 2003) –Newly published data show that treatment with 5 mg Actonel® (risedronate sodium tablets) daily reduced the risk of spinal fracture in ...
NEW YORK (Reuters Health) - The results of a new study suggest that Actonel (risedronate) provides greater fracture protection in the first year of therapy than does Fosamax (alendronate). Among ...
Aug. 18, 2005 -- The U.S. Food and Drug Administration (FDA) has approved calcitonin-salmon [rDNA origin] nasal spray for the treatment of osteoporosis in women more than five years after menopause; a ...
LONDON--(BUSINESS WIRE)--FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY A real world evidence study, presented at the 13 th International Conference on Osteoporosis, Arthritis and Musculoskeletal ...
Risedronate (Actonel) is a bisphosphonate which also includes the drugs alendronate prescribed for the treatment of Paget's disease of bone (a disease in which the formation of bone is abnormal) and ...
The FDA has approved a once-monthly dose of Actonel (risedronate sodium tablets, from Procter & Gamble and sanofi-aventis) for the treatment and prevention of postmenopausal osteoporosis. The 150mg ...
Teva Pharmaceutical says it has gained a green light in the USA to market its copycat version of Procter & Gamble’s $1 billion a year osteoporosis drug Actonel (risedronate) in three different doses, ...
ARDEE, Ireland, Oct. 11 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that the United States Food and Drug Administration (FDA) has ...
Teva announced the launch of Risedronate Sodium Tablets, the generic version of Warner Chilcott’s Actonel. Actonel is a bisphosphonate indicated for the treatment and prevention of osteoporosis in ...
Sanofi-Aventis has won approval in the USA and Europe to extend the indications for osteoporosis drug Actonel to include men with the disease, a group expected to increase in importance in the ...